期刊文献+

广州市乙型病毒性肝炎住院患者经济负担分析 被引量:3

Investigation and analysis on the financial burden to hepatitis B in-patients in Guangzhou
下载PDF
导出
摘要 目的评价广州市乙型病毒性肝炎(乙肝)住院患者不同人群(广州籍人口和外来人口)疾病经济负担,探索其影响因素。方法自行设计问卷调查患者疾病负担相关情况,采用多因素回归分析其影响因素。结果 305例病人中,广州籍患者年例均负担为36 980.0元,人均直接经济负担、间接负担分别为33 724.6元、3 255.4元。外来人口患者年例均负担为41 657.7元,人均直接经济负担、间接经济负担分别为39 840.6元、1 817.1元。影响广州籍患者经济负担的因素有户口性质、个人月均收入、抗病毒药物使用情况以及病情进展。病情进展及住院天数是影响外来人口经济负担的主要因素。结论针对不同人群做好预防工作可有效减轻乙肝患者经济负担。 Objective To explore the influence factors by investigating the financial burden to hepatitis B in- patients ( natives and non-natives) in Guangzhou. Methods Self-designed questionnaire was used to survey the influence factors of finacial burden to hepatitis B inpatients, and data were analyzed using multiple regression. Results 305 cases were investigated . To patients from native Guangzhou , the average finacial burden was ¥36980. 0, among which the direct and indirect finacial burden were ¥ 33724. 6, and ¥3255.4. separately,while to non-natives, the average finacial burden was ¥41657.7, and the direct and the indirect were ¥39840. 6, and ¥1817. 1 respectively. The results showed that the major risks of finacial burden was residency, personal income, the progress of disease and the use of antiviral drugs. Disease progression and days in hospital were the main factors to non-natives. Conclusions direct finacial burden was the key issue to HBV in-patients, and prevention of the disease among different populations can effectively reduce finacial burden.
出处 《广东药学院学报》 CAS 2011年第2期195-198,共4页 Academic Journal of Guangdong College of Pharmacy
基金 "十一五"国家科技重大专项(2008ZX10002-001)
关键词 乙型病毒性肝炎 住院患者 经济负担 hepatitis B virus hospitalized patients economic burden
  • 相关文献

参考文献6

  • 1中华人民共和国卫生部.国家卫生服务研究-1998年第二次国家卫生服务调查分析报告[R].北京:卫生部,1999..
  • 2宋小莺,杨美霞,华荣秋.上海市徐汇区流动人口传染病防制现况调查[J].上海预防医学,2004,16(10):469-470. 被引量:6
  • 3王旭东.广州市国民经济和社会统计公报[EB/OL].http://www.gzstats.gov.cn/tjfx/gztjfs/200903/t20090325_8899.htm[2010-11-10].
  • 4STEPHAN H,THOMAS S,KARIN B,et al.The economic burden of Hepatitis B in Germany[J].European Journal of Epidemiology,2000.16:173-176.
  • 5王南松,孟珺,周学琴.慢性乙型肝炎药物治疗的效果和费用分析[J].中国热带医学,2004,4(6):935-936. 被引量:4
  • 6ONG S C,LIM S G,LI S C.How big is the financial burden of hepatitis B to society?A cost-of-illness study of hepatitis B infection in Singapore[J].Journal of Viral Hepatitis,2009,16:53-63.

二级参考文献2

共引文献12

同被引文献61

  • 1石光,谢永富,刘秀颖,张勇.乙型肝炎经济负担的测算[J].中国初级卫生保健,2004,18(8):18-19. 被引量:14
  • 2付海龙,陈兴宝.慢性乙型肝炎病毒感染者医疗服务利用与费用分析[J].中华医院管理杂志,2004,20(7):406-409. 被引量:16
  • 3张洁,钱序,陈英耀.疾病负担研究进展[J].中国卫生经济,2005,24(5):69-71. 被引量:67
  • 4劳国琴,王佳良,吴勇.干扰素治疗慢性乙型肝炎病毒感染的经济效益[J].中国药房,2006,17(16):1223-1225. 被引量:3
  • 5吴疆,张卫,韩莉莉,林长缨,林晖,邢玉兰,高培,龚晓红,刘立荣,黄芳,刘健英,刘利英,王化勇,于海柱,刘秀军,唐雅清,蒲永兰,赵伟,王晨,张震,马立宪.北京市人群乙型肝炎血清流行病学研究[J].中华流行病学杂志,2007,28(6):555-557. 被引量:78
  • 6中华人民共和国卫生部.2010中国卫生统计年鉴[EB/OL].2012-02-17.http://www.mob.gov.cn/publicfiles/business/htmlfiles/zwgkzt/ptjnj/year2010/index2010.html.
  • 7World Health Organization. Hepatitis B (Revised August 2008) [EB/OL]. 2012-02-17. http://www. who. int/mediacentre/factsheets/fs204/en/.
  • 8Liang XF,Bi SL, Yang W, et al. Epidemiological serosurvey of Hepatitis B in China-Declining HBV prevalence due to Hepatitis B vaccination[J]. Vaccine, 2009,27: 6550-6557.
  • 9Guan ZQ,Dong Z H,Wang QH, et al. Cost of Chronic Hepatitis B Infection in China[J]. Journal of Clinical Gastroenterology, 2004,38(Suppl 3) : S175-S178.
  • 10Hu M,Chen W. Assessment of Total Economic Burden of Chronic Hepatitis B (CHB)- Related Diseases in Beijing and Guangzhou,China[J]. Value in Health, 2009,12 (Suppl 3) : S89-S92.

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部